January 16, 2018
The Monday morning sessions were focused on historical topics to put things into perspective and frame discussions on current practices and challenges. Three important practice challenges were discussed: (1) the current status of bioresorbable scaffold development and Abbott Vascular's decision to pull their product from the market; (2) metallic bioresorbable stents; and (3) magnesium bioresorbable stents.
Faculty Disclosure Vendor Supporters Program Agenda IAGS Video Menu